21 days
Whole Exome Sequencing (WES) with in silico analysis of a curated 154-gene panel
Genelist: See attached Form
Accredited NRL Laboratory
Once a week
This test is indicated for:
•Evaluation of patients with a personal and/or family history suggestive of a hereditary cancer syndrome
•Assessment of individuals with early-onset, multiple, rare, or syndromic malignancies
•Genetic evaluation where a broader hereditary cancer risk assessment is clinically appropriate
Whole Blood; ALTERNATE SPECIMENS: gDNA
3 mL
Whole blood in a purple-top EDTA tube (K2 EDTA or K3 EDTA)
No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.
This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |